Phase III win for Hansa Biopharma: “We Are Thrilled”

Swedish biotech Hansa Biopharma’s transplant drug imlifidase has met the primary efficacy endpoint in a registration-enabling Phase III study in the United States.

Kompauto Nordic AB

How the Foreign Office will promote Swedish life science exports

The broadness and innovative strength keep Swedish life science exports strong, but the protectionist tendencies in the world are worrying, says Camilla Melland...

LINK Medical recruits Swedish CEO

The Norwegian Contract Research Organization LINK Medical has recruited Anders Göransson as the new CEO.

Helsingborgsbolaget Aqilion utvecklar läkemedel mot eosinofil esofagit – fann drömsubstansen i Danmark

När Aqilion började utveckla ett läkemedel mot eosinofil esofagit klassades molekylen som ett särläkemedel. Men förekomsten av sjukdomen tycks nu öka.“Vi behövd...

Tolv tidigare FDA-chefer varnar för ny vaccinlinje

Tolv tidigare kommissionärer vid den amerikanska läkemedelsmyndigheten FDA uttrycker nu djup oro över förslag till förändringar i myndighetens vaccinreglering.

The First Multi-Technology System from ZEISS

Microscope and measuring machine in one.

FDA approves first non-opioid pain reliever in over 20 years

For the first time in decades, a new type of acute pain medication that is not an opioid has been approved in the USA.

RegFile AB

Sarah Lidé: ”Artificial intelligence must not replace authentic interactions”

Artificial intelligence must never become a replacement for authentic, even if messy, interactions with our fellow humankind, Sarah Lifé, Deputy CEO at Medicon ...

FDA lanserar ny färdplan för skräddarsydda terapier

Den amerikanska läkemedelsmyndigheten FDA har tagit fram en ny regulatorisk färdplan för personanpassade läkemedelsterapier vid sällsynta sjukdomar.

Samuel Lagercrantz: ”Kommer TACO-Trumps tullavtal hålla?”

Olika bud om USA-tullar på läkemedel har skapat osäkerhet. Nu har en överenskommelse slutits, men med Donald Trump som president vet man inte säkert om den komm...

ZEISS Lightfield 4D for instant volumetric high-speed imaging

Capturing physiological and neuronal processes in 3D.

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

Beta-blockers are often given unnecessarily, a study finds – “This will affect future practice”

Patients who have suffered a minor heart attack do not benefit from beta-blockers, according to a major new study that may change guidelines for cardiac care.

Lonza

The US is leaving the WHO

The newly installed US President, Donald Trump, has issued an executive order for the US to leave the World Health Organization, WHO.

Smartzoom 100 – The New Digital Microscope for Maximum Efficiency

Free webinar July 1, 9:00-9:45 AM CEST and 5:00-5:45 PM CEST.

“An entire industry is about to be wiped out”

According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.

ZEISS Insights: Measurement of bone plates and screws

Get free access to technical paper.

Xbrane enters licensing agreement with Indian generics giant

Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.

Controlled Pneumatics: pushing the boundaries of pneumatics

automation processes that are already known. It also opens up new opportunities, especially for controlling pressure and flow rate. Piezo valves, which enable v...

Cancer researcher: “We can do better and reduce suffering”

Lund University researcher Catharina Hagerling is developing innovative methods to understand metastatic cancer, aiming to create more targeted treatments for p...

Total pipeline of pharmaceutical companies reaches a record high – 22,921 medicines are currently being developed

Despite the difficult economic times, pharmaceutical companies have never developed as many new drugs as now.